12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Restless Legs Syndrome (RLS)Restless Legs Syndrome
Interventions
DRUG

ropinirole CR-RLS

Trial Locations (45)

16635

GSK Investigational Site, Duncansville

19444

GSK Investigational Site, Lafayette Hill

27835

GSK Investigational Site, Greenville

28204

GSK Investigational Site, Charlotte

29201

GSK Investigational Site, Columbia

30106

GSK Investigational Site, Austell

30342

GSK Investigational Site, Atlanta

31201

GSK Investigational Site, Macon

33026

GSK Investigational Site, Pembroke Pines

33511

GSK Investigational Site, Brandon

33707

GSK Investigational Site, St. Petersburg

35406

GSK Investigational Site, Tuscaloosa

35501

GSK Investigational Site, Jasper

40217

GSK Investigational Site, Louisville

40509

GSK Investigational Site, Lexington

41017

GSK Investigational Site, Crestview Hills

43017

GSK Investigational Site, Dublin

44195

GSK Investigational Site, Cleveland

45246

GSK Investigational Site, Cincinnati

46122

GSK Investigational Site, Danville

60007

GSK Investigational Site, Elk Grove Village

61761

GSK Investigational Site, Normal

63143

GSK Investigational Site, St Louis

66214

GSK Investigational Site, Lenexa

66606

GSK Investigational Site, Topeka

70503

GSK Investigational Site, Lafayette

70808

GSK Investigational Site, Baton Rouge

72205

GSK Investigational Site, Little Rock

73112

GSK Investigational Site, Oklahoma City

74104

GSK Investigational Site, Tulsa

75213

GSK Investigational Site, Dallas

78229

GSK Investigational Site, San Antonio

80033

GSK Investigational Site, Wheat Ridge

80111

GSK Investigational Site, Greenwood

85006

GSK Investigational Site, Phoenix

89104

GSK Investigational Site, Las Vegas

92108

GSK Investigational Site, San Diego

92801

GSK Investigational Site, Anaheim

97219

GSK Investigational Site, Portland

97239

GSK Investigational Site, Portland

97330

GSK Investigational Site, Corvallis

99362

GSK Investigational Site, Walla Walla

04210

GSK Investigational Site, Auburn

02135

GSK Investigational Site, Brighton

08755

GSK Investigational Site, Toms River

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00373542 - 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome | Biotech Hunter | Biotech Hunter